Ex vivo purging by adenoviral p53 gene therapy does not affect NOD-SCID repopulating activity of human CD34+ cells.
Hirai M, LaFace D, Robinson S, Kelsey L, Johnson R, Wen SF, Warkentin P, Mills K, Vaillancourt M, Chavez J, Leutzinger C, Sumegi J, Neugebauer S, Lehman J, Talmadge C, Maneval D, Talmadge J.
Hirai M, et al. Among authors: laface d.
Cancer Gene Ther. 2001 Dec;8(12):936-47. doi: 10.1038/sj.cgt.7700390.
Cancer Gene Ther. 2001.
PMID: 11781656